PART I: PRIMARY TUMOUR EVALUATION AND STAGING
1. Tumours of the oral cavity and pharynx
Kunwar S. S. Bhatia, Ann D. King, and Robert Hermans
2. Paranasal sinus and nasal cavity neoplasms
Sofia Otero and Tim Beale
3. Laryngeal tumours
Philip Touska, Steve Connor, and Robert Hermans
4. Thyroid cancer
Gitta Madani and Polly S. Richards
5. Mediastinal tumours
Jonathan Goldin
6. Lung cancer
Stephen M. Ellis and Zelena Aziz
7. Pleural tumours
Bhavin Rawal and Sujal R. Desai
8. Breast cancer
Sarah J. Vinnicombe and Alexandra Athanasiou
9. Oesophageal cancer
Nyree Griffin, Jason Dunn, and Lee Alexander Grant
10. Gastric cancer
Jacob S. Ecanow and Richard M. Gore
11. Primary tumours of the liver and biliary tract
Hero K. Hussain and Mohammad Abu Shattal
12. Pancreatic malignancy
Giovanni Morana, Alex Faccinetto, and Michele Fusaro
13. Renal cancer
Conrad von Stempel, Lee Alexander Grant, Miles Walkden, and Navin Ramachandran
14. Primary adrenal malignancy
Ayshea Hameeduddin, Anju Sahdev, and Rodney H. Reznek
15. Primary retroperitoneal tumours
Isaac R. Francis, Richard H. Cohan, and William R. Burns
16. Bladder cancer
Anju Sahdev
17. Prostate cancer
Jurgen J. Fütterer, Fillip Kossov, and Henkjan Huisman
18. Testicular cancer
Edward Nganga and Aslam Sohaib
19. Ovarian cancer
Stephanie Nougaret, Helen Addley, Evis Sala, and Anju Sahdev
20. Cervical and uterine tumours
Rosemarie Forstner and Andrea Rockall
21. Colorectal cancer
Svetlana Balyasnikova and Gina Brown
22. Primary bone tumours
Jennifer N. Murphy, Steven L. J. James, Murali Sundaram, and A. Mark Davies
23. Soft tissue sarcomas
Christina Messiou, Dirk Strauss, and Eleanor Moskovic
24. Neuroendocrine tumours
Sairah R. Khan, Kathryn L. Wallitt, Adil Al-Nahhas, and Tara D. Barwick
PART II: HAEMATOLOGICAL MALIGNANCY AND IMMUNE RELATED MALIGNANCY
25. Lymphoma
Sarah J. Vinnicombe and Rodney J. Hicks
26. Multiple myeloma
Conor D. Collins
PART III: METASTASES
27. Brain metastases
Anant Subramanian Krishnan and Jane Evanson
28. Lymph node metastases
Dow-Mu Koh and Gigin Lin
29. Lung and pleural metastases
Matthew Gilman and Amita Sharma
30. Bone metastases
Rupert Berkeley, Muaaze Ahmad, and Rikin Hargunani
31. Liver and spleen metastases
Wolfgang Schima, Helmut Kopf, and Claus Kölblinger
32. Adrenal metastases
Khawaja Shahabuddin, Rodney H. Reznek, and Anju Sahdev
33. Peritoneal metastases
Louisa Firmin and Zahir Amin
PART IV: DISEASE RESPONSE AND TREATMENT
34. Assessment of response to treatment
Lawrence H. Schwartz, Binsheng Zhao, and Marius E. Mayerhoefer
35. Tumour-specific disease response criteria
Katja De Paepe and Nina Tunariu
36. Immunotherapy response
Bernhard Gebauer
PART V: EFFECTS ON NORMAL TISSUE AND COMPLICATIONS OF TREATMENTS
37. Oncological effects on the central nervous system
Jane Evanson
38. Effects of treatment on the thorax
Dhakshina Moorthy Ganeshan, Herman I. Libshitz, and Revathy B. Iyer
39. Effects of treatment on the abdomen and pelvis
Rohit Kochhar and Philip Borg
40. Effects of treatment on bone and bone marrow
Lia A. Moulopoulos and Vassilis Koutoulidis
PART VI: FUNCTIONAL AND MOLECULAR IMAGING
41. PET-CT: Principles and clinical applications
Mario Jreige, Marie Nicod-Lalonde, John O. Prior, and Niklaus Schaefer
42. Functional imaging and emerging techniques in MRI
Roberto García-Figueiras, Anwar Padhani, and Sandra Baleato-González
43. Functional imaging and emerging techniques in CT
Vicky Goh, Christian Kelly-Morland, and Davide Prezzi
44. Non-FDG radionuclide imaging and targeted therapies
Luigi Aloj and Ferdia A. Gallagher
Index
This comprehensive reference provides an overview of the general principles of cancer staging, as well as specific discussions of each tumour type across the body, including lymphoma and haematological malignancies. For each tumour, the pattern of disease involvement and disease spread are emphasized, the state-of-the-art imaging features surveyed, and the latest tumour staging and methods to assess treatment response are addressed. Separate sections discuss metastatic disease and the effects of treatment on normal and diseased tissues. The final section of the book highlights emerging functional and molecular imaging techniques to evaluate the different biological hallmarks of cancer.
